<code id='48815CA7B9'></code><style id='48815CA7B9'></style>
    • <acronym id='48815CA7B9'></acronym>
      <center id='48815CA7B9'><center id='48815CA7B9'><tfoot id='48815CA7B9'></tfoot></center><abbr id='48815CA7B9'><dir id='48815CA7B9'><tfoot id='48815CA7B9'></tfoot><noframes id='48815CA7B9'>

    • <optgroup id='48815CA7B9'><strike id='48815CA7B9'><sup id='48815CA7B9'></sup></strike><code id='48815CA7B9'></code></optgroup>
        1. <b id='48815CA7B9'><label id='48815CA7B9'><select id='48815CA7B9'><dt id='48815CA7B9'><span id='48815CA7B9'></span></dt></select></label></b><u id='48815CA7B9'></u>
          <i id='48815CA7B9'><strike id='48815CA7B9'><tt id='48815CA7B9'><pre id='48815CA7B9'></pre></tt></strike></i>

          fashion

          fashion

          author:leisure time    Page View:5457
          Illustration of a person walking across a tightrope, trying to balance.
          Adobe

          Hospitals are telling government officials it would be illegal to claw back $7.8 billion as part of a remedy that is making hospitals whole over underpaid drug discounts — and they may sue if that plan goes into effect.

          The industry is walking a tightrope by trying to maximize the amount of money hospitals can keep. Lobbyists are praising federal officials for agreeing to dole out billions of dollars in future, lump-sum payments, but they are also pressuring Medicare not to offset a penny of those funds.

          advertisement

          For several years during the Trump administration, Medicare cut payments for hospitals’ drugs under the federal 340B drug discount program, but the Supreme Court invalidated that policy in 2018. In July, Medicare proposed a solution: Hospitals would get $9 billion to cover what they are owed under the 340B program, but to offset those costs, the government would recoup $7.8 billion.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Cassava Sciences’ Alzheimer’s clinical trials should be halted
          Cassava Sciences’ Alzheimer’s clinical trials should be halted

          MollyFerguson/STATTheFoodandDrugAdministrationshouldhaltCassavaSciences’ongoingclinicaltrialsinAlzhe

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

          AdobeHospitals,pharmacies,andotherhealthcareprovidersaregettingstuckinaninsuranceprocessinglogjamaft